Scivision Biotech (TPE:1786) Institutional Ownership: 1.19% (As of Aug. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1786 Scivision Biotech Inc TPE:1786
75 GF Score
Price NT$49.65
GF Value NT$108.50
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Scivision Biotech Institutional Ownership?

Scivision Biotech TPE:1786 -0.70% 75 Institutional Ownership is 1.19% as of Aug. 07, 2026. GuruFocus rates TPE:1786 with a GF Score™ of 75/100 and a GF Value™ of NT$108.50 (Possible Value Trap). The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Scivision Biotech's institutional ownership is 1.19%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Scivision Biotech's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Scivision Biotech's Float Percentage Of Total Shares Outstanding is 0.00%.

Scivision Biotech Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Scivision Biotech's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scivision Biotech Institutional Ownership Chart

Scivision Biotech Historical Data

The historical data trend for Scivision Biotech can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 1.34 1.30 1.31 1.36 1.38 1.44 1.24 1.15 1.17 1.19
TPE:1786
75GF Score
Scivision Biotech Inc TPE:1786
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scivision Biotech Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 1.19% mean?
Scivision Biotech (TPE:1786) has a Institutional Ownership of 1.19% as of Aug. 07, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Scivision Biotech and its competitors.
Is Scivision Biotech's Institutional Ownership too high?
Scivision Biotech's current Institutional Ownership is 1.19%. Overall, Scivision Biotech has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Scivision Biotech's Institutional Ownership compare to ISRG and BDX?
Scivision Biotech's Institutional Ownership of 1.19% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Scivision Biotech and its competitors. Scivision Biotech's current Institutional Ownership is 1.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scivision Biotech stock overvalued right now?
Based on GuruFocus' analysis, Scivision Biotech (TPE:1786) is currently considered Possible Value Trap. The stock's GF Value™ is NT$108.50, compared to a current price of NT$49.65 — trading 54.2% below its estimated fair value. The current Institutional Ownership is 1.19%. Scivision Biotech's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Scivision Biotech (TPE:1786), the current Institutional Ownership is 1.19% as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scivision Biotech (TPE:1786) Overvalued in 2026?

Based on GuruFocus' analysis, Scivision Biotech stock appears to be undervalued. The current stock price of NT$49.65 is trading 54.2% below its estimated GF Value™ of NT$108.50. GuruFocus considers Scivision Biotech to be Possible Value Trap.

Key valuation signals for TPE:1786:

  • Institutional Ownership: 1.19%
  • GF Value™: NT$108.50 vs. price of NT$49.65 (54.2% below fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the TPE:1786 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Scivision Biotech Business Description

Address No. 1, South 1st Road, Qianzhen District, Kaohsiung, TWN, 806
Scivision Biotech Inc is engaged in the manufacturing and distribution of hyaluronic acid medical supplies in Taiwan. It offers medical devices, including absorbable adhesion barriers, dermal implants, synovial fluid supplements, and intravesical instillation.
75GF Score

Get the complete analysis for TPE:1786

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$49.65
Price
NT$108.50
GF Value